chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: VARZOS
Symptoms: Pain in extremity
Clinical narrative: Patient who is complaining of sore arm; This case was reported by a physician via call center representative and described the occurrence of pain in arm in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   In September 2020, the patient received the 2nd dose of Shingrix. On an unknown date, less than 6 months after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown.   The reporter considered the pain in arm to be possibly related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient experienced sore arm that she relates back to her second Shingrix vaccination. The patient denies any nodule or visible abnormality. The reporter asked if was this a known issue and any advice would be appreciated. The consent to follow-up was granted.
Sex: U
Vaccine: VARZOS
Symptoms: Emotional distress, Injection site pain
Clinical narrative: pain at the injection site; it bothers me from time to time; This case was reported by a consumer via interactive digital media and described the occurrence of injection site pain in a 67-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On 30th January 2021, the patient received Shingrix. On an unknown date, less than 2 weeks after receiving Shingrix, the patient experienced injection site pain and emotional distress. On an unknown date, the outcome of the injection site pain and emotional distress were not recovered/not resolved.   It was unknown if the reporter considered the injection site pain and emotional distress to be related to Shingrix.  Additional details were provided as follows: The patient had reported the case for herself/himself. The age at vaccination was not reported, however it could be 66 or 67 years. The patient received shingles shot 10 days ago from the reporting date and he/she was still getting a pain at the injection site. The reporter mentioned that nothing was  too bad, but it bothers him/her from time to time and asked if he/she should be concerned. The follow-up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect dose administered, Product preparation issue
Clinical narrative: Shingrix was giving with another diluent; Shingrix was giving with another diluent; This case was reported by a nurse and described the occurrence of inappropriate preparation of medication in a adult patient who received Herpes zoster (Shingrix) (batch number M972X, expiry date 9th October 2022) for prophylaxis.   On 9th December 2020, the patient received Shingrix. On 9th December 2020, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows:  The age at vaccination was not reported.  The age group was not reported but was captured as adult as per vaccine indication.  The Shingrix was giving with another diluent, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The NP found only a vial and she is looking which of the 3 patients who received Shingrix on that day is involved in this situation. The HCP needs time to look the information. The reporter consent to follow up.
Age: 56.0
Sex: F
Vaccine: VARZOS
Symptoms: Social problem
Clinical narrative: First dose in NOV 2019 / second dose in SEP 2020 / due to COVID concern; This case was reported by a consumer via call center representative and described the occurrence of social problem in a 57-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of pain in extremity (1st dose received on an unknown date, refer case number US2021004407.).   In September 2020, the patient received the 2nd dose of Shingrix. In September 2020, unknown after receiving Shingrix, the patient experienced social problem. On an unknown date, the outcome of the social problem was unknown.  Additional details were provided as follows:  The age at vaccination was not reported.  The patient received dose of 2nd dose of Shingrix in left arm. The patient was unable to space 2nd dose of Shingrix within 6 months due to COVID concern and travel plans. The reporter did not consent to follow up. This case has been linked with US2021AMR005804, reported by same reporter and same patient.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR005804:Same reporter US-GLAXOSMITHKLINE-US2021004407:Same reporter. Case for reporter's mom.
Age: 72.0
Sex: M
Vaccine: VARZOS
Symptoms: Pain in extremity
Clinical narrative: had Pain around the titanium rod in leg; This case was reported by a physician via call center representative and described the occurrence of leg pain in a 72-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included internal fixation of fracture (Titanium Rod in leg).   On 10th January 2021, the patient received the 1st dose of Shingrix (intramuscular). On 11th January 2021, 1 days after receiving Shingrix, the patient experienced leg pain. On an unknown date, the outcome of the leg pain was unknown.   It was unknown if the reporter considered the leg pain to be related to Shingrix.  Additional details were reported as follows: The patient was a physician. The patient received 1st dose of Shingrix and on the next day, the patient had pain around the titanium rod in leg upon awakening. The patient disconnected the call early due to time restraints, so all information was not available.
Sex: F
Vaccine: VARZOS
Symptoms: Immediate post-injection reaction, Injection site pain, Pain in extremity
Clinical narrative: Injection site hurts when she uses her left arm; Arm hurt immediately / became increasingly worse; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of no adverse event (1st dose received on an unknown date).   On an unknown date, the patient received the 2nd dose of Shingrix (intramuscular). On an unknown date, immediately after receiving Shingrix, the patient experienced injection site pain and pain in arm. On an unknown date, the outcome of the injection site pain and pain in arm were not recovered/not resolved.   It was unknown if the reporter considered the injection site pain and pain in arm to be related to Shingrix.  Additional details were reported as follows: This case was reported by patient herself. The age at vaccination was not reported. 2 years ago, the patient received 2nd dose of Shingrix vaccines and her arm hurt immediately and became increasingly worse. The patient stated that her left arm was painful to touch, and that the injection site hurts when she uses her left arm. The reporter consented to follow-up.
Sex: M
Vaccine: VARZOS
Symptoms: Fatigue, Malaise
Clinical narrative: fatigue; malaise; This case was reported by a medical representative via call center representative and described the occurrence of fatigue in a adult male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 1st February 2021, the patient received the 1st dose of Shingrix. In February 2021, less than a week after receiving Shingrix, the patient experienced fatigue and malaise. On an unknown date, the outcome of the fatigue and malaise were not recovered/not resolved.   It was unknown if the reporter considered the fatigue and malaise to be related to Shingrix.  Additional information was provided as follows: The age at vaccination was not reported. On Monday, the reporter who reported that doctor himself had his first Shingrix shot and experienced fatigue and malaise. The reporter did not consent to follow up.
Sex: M
Vaccine: VARZOS
Symptoms: Bell's palsy, Cerebrovascular accident, Malaise
Clinical narrative: had a stroke; Bell's Palsy; he didnt feel well; This case was reported by a consumer via call center representative and described the occurrence of stroke in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced stroke (serious criteria hospitalization and GSK medically significant), bell's palsy (serious criteria hospitalization and GSK medically significant) and feeling unwell. On an unknown date, the outcome of the stroke, bell's palsy and feeling unwell were unknown.   It was unknown if the reporter considered the stroke, bell's palsy and feeling unwell to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient stated that after he got his second dose of shingrix he didnt feel well, went to the hospital, had a stroke and Bell's Palsy. The reporter did not consent to follow-up.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cerebral haemorrhage, Ear swelling, Eye swelling, Hypersensitivity, Lip swelling
Clinical narrative: Brain hemorrhage; Allergic reaction; Face, eyes, ears, lips and hands were swollen; Face, eyes, ears, lips and hands were swollen; Face, eyes, ears, lips and hands were swollen; Face, eyes, ears, lips and hands were swollen; Face, eyes, ears, lips and hands were swollen; Hands were itching; A spontaneous report (United States) was received from a consumer a 74-year-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced brain hemorrhage, allergic reaction, face, eyes, ears, lips and hands were swollen, and hands were itching.   The patient's medical history, as provided by the reporter included allergy to gadavist and tromethamine. The concomitant medications reported included diltiazem, atorvastatin calcium, ezetimibe and hydrochlorothiazide for unspecified indications.  On 15 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 011LZ0A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   On 18 Jan 2021, the patient experienced brain hemorrhage, allergic reaction, face, eyes, ears, lips and hands were swollen, lips looked as an overdose of botox and hands were itching. The patient was taken to the emergency room (ER) and treated with intravenous diphenhydramine and steroids. It was stated that the swelling lasted 36 hours and the patient was prescribed prednisone to treat symptoms after leaving ER.   Action taken with mRNA-1273 in response to the events was not provided. However, the healthcare professional recommended patient to cease with the vaccination series due to probability of the patient being allergic to tromethamine.  The events, allergic reaction, face, eyes, ears, lips and hands were swollen, and hands were itching, were considered resolved on 20 Jan 2021. The outcome for the event, brain hemorrhage, was unknown.; Reporter's Comments: This case concerns a 74 year old, female patient, with a medical history of allergy to gadavist and tromethamine, who experienced a serious unexpected event of Cerebral hemorrhage, hypersensitivity after receiving first dose of mRNA-1273. Very limited information regarding this event has been provided at this time. Further information has been requested.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Peripheral swelling, Pruritus, Swelling face
Clinical narrative: Brain hemorrhage; Allergic reaction; Face, eyes, ears, lips and hands were swollen; Face, eyes, ears, lips and hands were swollen; Face, eyes, ears, lips and hands were swollen; Face, eyes, ears, lips and hands were swollen; Face, eyes, ears, lips and hands were swollen; Hands were itching; A spontaneous report (United States) was received from a consumer a 74-year-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced brain hemorrhage, allergic reaction, face, eyes, ears, lips and hands were swollen, and hands were itching.   The patient's medical history, as provided by the reporter included allergy to gadavist and tromethamine. The concomitant medications reported included diltiazem, atorvastatin calcium, ezetimibe and hydrochlorothiazide for unspecified indications.  On 15 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 011LZ0A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   On 18 Jan 2021, the patient experienced brain hemorrhage, allergic reaction, face, eyes, ears, lips and hands were swollen, lips looked as an overdose of botox and hands were itching. The patient was taken to the emergency room (ER) and treated with intravenous diphenhydramine and steroids. It was stated that the swelling lasted 36 hours and the patient was prescribed prednisone to treat symptoms after leaving ER.   Action taken with mRNA-1273 in response to the events was not provided. However, the healthcare professional recommended patient to cease with the vaccination series due to probability of the patient being allergic to tromethamine.  The events, allergic reaction, face, eyes, ears, lips and hands were swollen, and hands were itching, were considered resolved on 20 Jan 2021. The outcome for the event, brain hemorrhage, was unknown.; Reporter's Comments: This case concerns a 74 year old, female patient, with a medical history of allergy to gadavist and tromethamine, who experienced a serious unexpected event of Cerebral hemorrhage, hypersensitivity after receiving first dose of mRNA-1273. Very limited information regarding this event has been provided at this time. Further information has been requested.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cerebral haemorrhage, Drug hypersensitivity, Ear swelling, Erythema, Eye swelling
Clinical narrative: Brain hemorrhage; Allergic reaction; Face, eyes, ears, lips and hands were swollen; Face, eyes, ears, lips and hands were swollen; Face, eyes, ears, lips and hands were swollen; Face, eyes, ears, lips and hands were swollen; Face, eyes, ears, lips and hands were swollen; Hands were itching; A spontaneous report (United States) was received from a consumer a 74-year-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced brain hemorrhage, allergic reaction, face, eyes, ears, lips and hands were swollen, and hands were itching.   The patient's medical history, as provided by the reporter included allergy to gadavist and tromethamine. The concomitant medications reported included diltiazem, atorvastatin calcium, ezetimibe and hydrochlorothiazide for unspecified indications.  On 15 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 011LZ0A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   On 18 Jan 2021, the patient experienced brain hemorrhage, allergic reaction, face, eyes, ears, lips and hands were swollen, lips looked as an overdose of botox and hands were itching. The patient was taken to the emergency room (ER) and treated with intravenous diphenhydramine and steroids. It was stated that the swelling lasted 36 hours and the patient was prescribed prednisone to treat symptoms after leaving ER.   Action taken with mRNA-1273 in response to the events was not provided. However, the healthcare professional recommended patient to cease with the vaccination series due to probability of the patient being allergic to tromethamine.  The events, allergic reaction, face, eyes, ears, lips and hands were swollen, and hands were itching, were considered resolved on 20 Jan 2021. The outcome for the event, brain hemorrhage, was unknown.; Reporter's Comments: This case concerns a 74 year old, female patient, with a medical history of allergy to gadavist and tromethamine, who experienced a serious unexpected event of Cerebral hemorrhage, hypersensitivity after receiving first dose of mRNA-1273. Very limited information regarding this event has been provided at this time. Further information has been requested.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lip swelling, Magnetic resonance imaging head, Peripheral swelling, Product administration interrupted, Pruritus
Clinical narrative: Brain hemorrhage; Allergic reaction; Face, eyes, ears, lips and hands were swollen; Face, eyes, ears, lips and hands were swollen; Face, eyes, ears, lips and hands were swollen; Face, eyes, ears, lips and hands were swollen; Face, eyes, ears, lips and hands were swollen; Hands were itching; A spontaneous report (United States) was received from a consumer a 74-year-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced brain hemorrhage, allergic reaction, face, eyes, ears, lips and hands were swollen, and hands were itching.   The patient's medical history, as provided by the reporter included allergy to gadavist and tromethamine. The concomitant medications reported included diltiazem, atorvastatin calcium, ezetimibe and hydrochlorothiazide for unspecified indications.  On 15 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 011LZ0A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   On 18 Jan 2021, the patient experienced brain hemorrhage, allergic reaction, face, eyes, ears, lips and hands were swollen, lips looked as an overdose of botox and hands were itching. The patient was taken to the emergency room (ER) and treated with intravenous diphenhydramine and steroids. It was stated that the swelling lasted 36 hours and the patient was prescribed prednisone to treat symptoms after leaving ER.   Action taken with mRNA-1273 in response to the events was not provided. However, the healthcare professional recommended patient to cease with the vaccination series due to probability of the patient being allergic to tromethamine.  The events, allergic reaction, face, eyes, ears, lips and hands were swollen, and hands were itching, were considered resolved on 20 Jan 2021. The outcome for the event, brain hemorrhage, was unknown.; Reporter's Comments: This case concerns a 74 year old, female patient, with a medical history of allergy to gadavist and tromethamine, who experienced a serious unexpected event of Cerebral hemorrhage, hypersensitivity after receiving first dose of mRNA-1273. Very limited information regarding this event has been provided at this time. Further information has been requested.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Scan with contrast, Swelling face
Clinical narrative: Brain hemorrhage; Allergic reaction; Face, eyes, ears, lips and hands were swollen; Face, eyes, ears, lips and hands were swollen; Face, eyes, ears, lips and hands were swollen; Face, eyes, ears, lips and hands were swollen; Face, eyes, ears, lips and hands were swollen; Hands were itching; A spontaneous report (United States) was received from a consumer a 74-year-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced brain hemorrhage, allergic reaction, face, eyes, ears, lips and hands were swollen, and hands were itching.   The patient's medical history, as provided by the reporter included allergy to gadavist and tromethamine. The concomitant medications reported included diltiazem, atorvastatin calcium, ezetimibe and hydrochlorothiazide for unspecified indications.  On 15 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 011LZ0A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   On 18 Jan 2021, the patient experienced brain hemorrhage, allergic reaction, face, eyes, ears, lips and hands were swollen, lips looked as an overdose of botox and hands were itching. The patient was taken to the emergency room (ER) and treated with intravenous diphenhydramine and steroids. It was stated that the swelling lasted 36 hours and the patient was prescribed prednisone to treat symptoms after leaving ER.   Action taken with mRNA-1273 in response to the events was not provided. However, the healthcare professional recommended patient to cease with the vaccination series due to probability of the patient being allergic to tromethamine.  The events, allergic reaction, face, eyes, ears, lips and hands were swollen, and hands were itching, were considered resolved on 20 Jan 2021. The outcome for the event, brain hemorrhage, was unknown.; Reporter's Comments: This case concerns a 74 year old, female patient, with a medical history of allergy to gadavist and tromethamine, who experienced a serious unexpected event of Cerebral hemorrhage, hypersensitivity after receiving first dose of mRNA-1273. Very limited information regarding this event has been provided at this time. Further information has been requested.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: Upper arm muscle pain for two days following vaccine at injection site, after 2nd day all pain was gone.  Day 8 Arm muscle pain returned for an additional 2 days. Red line under injection site - after 2 days pain was gone.  No treatment taken
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Nausea
Clinical narrative: Injection on Friday - on Saturday: Pain in arm of injection, blotchy red patches going down arm of injection, extreme joint pain, headache, fever, chills, extreme fatigue. Sunday: arm continues splotchy red, headache, chills, fever, extreme fatigue. Monday: nausea, headache, chills, extreme fatigue
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia, Rash macular
Clinical narrative: Injection on Friday - on Saturday: Pain in arm of injection, blotchy red patches going down arm of injection, extreme joint pain, headache, fever, chills, extreme fatigue. Sunday: arm continues splotchy red, headache, chills, fever, extreme fatigue. Monday: nausea, headache, chills, extreme fatigue
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pyrexia, Skin warm, Tenderness
Clinical narrative: Warm to touch, red, tender, febrile (Low trade). Remains 3 days s/p completing series
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Injection site erythema, Injection site rash, Injection site warmth, Muscle spasms
Clinical narrative: Red rash around injection site that was warm to touch Complained of headaches and cramps in calves. Resolved in 2 days without treatment.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Chills, Dizziness, Dyspnoea, Electrocardiogram
Clinical narrative: Day 1  Rapid heart rate, Fatigue, chills, slight temp,    Slept off and on 24 hrs thru Day 2 Day   3  Red rash over both arm pitts, below breasts, upper thighs,  Rapid heart pulse, irregular pulse, called and visited  Cardiology Clinic for Ekg confirmed PVCs Day 4    Light headed, dizziness affecting gait, forced  lying down , general brain fog, rash continued, shortness of breath, rapid heart rate, went to ER, saw nurse for Ekg, blood work, blood pressure, Tylenol 100mg 3x a day Day 5
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Gait disturbance, Heart rate increased, Heart rate irregular
Clinical narrative: Day 1  Rapid heart rate, Fatigue, chills, slight temp,    Slept off and on 24 hrs thru Day 2 Day   3  Red rash over both arm pitts, below breasts, upper thighs,  Rapid heart pulse, irregular pulse, called and visited  Cardiology Clinic for Ekg confirmed PVCs Day 4    Light headed, dizziness affecting gait, forced  lying down , general brain fog, rash continued, shortness of breath, rapid heart rate, went to ER, saw nurse for Ekg, blood work, blood pressure, Tylenol 100mg 3x a day Day 5
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rash, Rash erythematous, Ventricular extrasystoles
Clinical narrative: Day 1  Rapid heart rate, Fatigue, chills, slight temp,    Slept off and on 24 hrs thru Day 2 Day   3  Red rash over both arm pitts, below breasts, upper thighs,  Rapid heart pulse, irregular pulse, called and visited  Cardiology Clinic for Ekg confirmed PVCs Day 4    Light headed, dizziness affecting gait, forced  lying down , general brain fog, rash continued, shortness of breath, rapid heart rate, went to ER, saw nurse for Ekg, blood work, blood pressure, Tylenol 100mg 3x a day Day 5
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Injection site rash, Injection site warmth
Clinical narrative: Hot, itchy, painful circular rash at injection site
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Induration, Rash, Skin lesion
Clinical narrative: first rash, then large hardened red area with a lesion-looking red mark, all in all approximately 5" diameter
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Hypertension, Paraesthesia oral
Clinical narrative: Pt. left tent 13 at 8:20 am.  At observation site at 8:30 am, pt. was complaining of tingling lips and feeling like blood pressure was high.  Paramedics assessed vitals 160/90.  Pt. was monitored until symptoms subsised.  Paramedics released to leave at 8:55 am.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Induration, Rash erythematous, Rash papular, Rash pruritic
Clinical narrative: Hard area and raised red itchy rash the size of a dollar bill
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Swelling
Clinical narrative: Seven days after first shot, the area of my upper arm under the vaccination site became quite itchy and a bit red and swollen.  Hydrocortizone cream stops the itchiness.  Still swollen but it's not a problem
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Lethargy
Clinical narrative: Systemic: Exhaustion / Lethargy-Medium
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: Redness, swelling, itchy at injection site like a bullseye
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Error: Booster Given Too Early
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Error: Booster Given Too Early
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Error: Booster Given Too Early
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Pain
Clinical narrative: chills, body aches and headache
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash
Clinical narrative: Rash around injection site
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure abnormal, Dizziness, Heart rate decreased, Hyperhidrosis, Pallor
Clinical narrative: 0715: pt c/o dizziness, "can't see," "fuzzy" post 2nd dose of Pfizer COVID-19 vaccine. pt a&ox3, pale, and diaphoretic. VS 65/39, HR 51, RR 16, SPO2 99 on RA, T 98.4. laid patient on the ground with bilateral extremities above level of the heart. 0720: VS BP 97/53, HR 66, RR 16, SPO2 98 on RA. pt states she feels better. CODE BLUE team arrived at 0723. Blood glucose = 97. pt refused transfer to the ED for further evaluation.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Vision blurred
Clinical narrative: 0715: pt c/o dizziness, "can't see," "fuzzy" post 2nd dose of Pfizer COVID-19 vaccine. pt a&ox3, pale, and diaphoretic. VS 65/39, HR 51, RR 16, SPO2 99 on RA, T 98.4. laid patient on the ground with bilateral extremities above level of the heart. 0720: VS BP 97/53, HR 66, RR 16, SPO2 98 on RA. pt states she feels better. CODE BLUE team arrived at 0723. Blood glucose = 97. pt refused transfer to the ED for further evaluation.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Injection site erythema, Injection site pain, Injection site swelling, Neck pain
Clinical narrative: 11 days post-vaccine (on the morning of 2/22), I woke to find that the area surrounding the injection site in my left arm was a little bit red and sore.  By the end of the day, the soreness in my arm radiated up into the left side of my neck.  I applied a heating pad, took a warm bath and went to bed early.  This morning, my neck is a little better but the arm is more sore and the red area has gotten larger and is swollen.  The pain med-to-mild and does not restrict range of motion or use of my arm.  No distinct pattern or broken skin.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Pain, Pyrexia
Clinical narrative: Started with bad chills which lasted about 45 minutes then slowly decreased in frequency and duration overnight. Also body aches, joint pain (minor). Next morning (Saturday) temp 101.5 and fatigue.  Took 2  500mg Acetaminophen.  Slept and rested that next day.  Temp decreased over the day . Next day (Sunday) minor fatigue but no temp or body aches etc.  Feeling fine by Sunday afternoon.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash
Clinical narrative: rash at injection site a week after the shot
Age: 100.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Error: Wrong Dose of Vaccine - Too Low
Age: 57.0
Sex: F
Vaccine: PPV, VARZOS
Symptoms: Tachycardia
Clinical narrative: tachycardia heart rate in the teens
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Error: Wrong Dose of Vaccine - Too Low
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Feeling abnormal, Heart rate, Loss of consciousness, Pallor
Clinical narrative: PT STATES THAT SHE WAS FEELING WEIRD . PT WAS PALE, STARTED SHAKING AND SAYING THAT SHE WAS GOING TO PASS   OUT. PT SLUMPED IN HER CHAIR, SUPPORTED BY 2 RNS, PT UNABLE TO ANSWER PROMPTS. PT TRANSFERRED TO ED. BEDSIDE VITALS IN OBSERVATIONBP 90/66 HR 79
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor, Unresponsive to stimuli
Clinical narrative: PT STATES THAT SHE WAS FEELING WEIRD . PT WAS PALE, STARTED SHAKING AND SAYING THAT SHE WAS GOING TO PASS   OUT. PT SLUMPED IN HER CHAIR, SUPPORTED BY 2 RNS, PT UNABLE TO ANSWER PROMPTS. PT TRANSFERRED TO ED. BEDSIDE VITALS IN OBSERVATIONBP 90/66 HR 79
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Error: Wrong Dose of Vaccine - Too High
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure abnormal, Emotional distress, Palpitations
Clinical narrative: PATIENT IN OBS AREA FOR 10 MIN WHE SHE BEGAN TO FEEL"PANICKY WITH HEART RACING. HR 144 BP 148/88.   REDIRECTION AND REFOCUS ATTEMPTED WITH GOOD EFFECT AS NOTED BY HR DECREASE TO 88-103 AND BP 130/88 100%  PATIENT DENIED SOB AND CHEST PAIN. MARKED DECREASE IN SYMPTOMS WHEN CALM, HOWEVER, DIFFICULT TO KEEP HER CALM AND SHE WAS CONVINCED THE VACCINE WAS THE CAUSE OF THE SYMPTOMS. DECISION MADE TO TAKE PATIENT TO THE ER     FOR EVALUATION. VS ON D/C 98- 138/73 100%; REPORT GIVEN TO RN ER CHARGE
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Hyperhidrosis, Pallor
Clinical narrative: 0720: pt c/o feeling "faint, lightheaded, dizzy" 10 minutes post second dose of Pfizer COVID-19 vaccine.  pt appears pale and diaphoretic. laid to the ground with bilateral lower extremities elevated above level of heart. pt states he feels better a few minutes after intervention. VS BP 121/76, HR 68, RR 16, SPO2 96 on RA, T 97.9.
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Presyncope
Clinical narrative: 0720: pt c/o feeling "faint, lightheaded, dizzy" 10 minutes post second dose of Pfizer COVID-19 vaccine.  pt appears pale and diaphoretic. laid to the ground with bilateral lower extremities elevated above level of heart. pt states he feels better a few minutes after intervention. VS BP 121/76, HR 68, RR 16, SPO2 96 on RA, T 97.9.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Eye swelling, Lip swelling, Mouth swelling, Swelling face
Clinical narrative: Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Mild, Additional Details: Swelling and redness in cheeks. Patient described feeling swelling in lips but no swelling was visible. She was given 25mg Benadryl and monitored for approximately an hour with no additional swelling seen and was driven home by a relative.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Swollen tongue
Clinical narrative: Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Mild, Additional Details: Swelling and redness in cheeks. Patient described feeling swelling in lips but no swelling was visible. She was given 25mg Benadryl and monitored for approximately an hour with no additional swelling seen and was driven home by a relative.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Moderna COVID-19 Vaccine EUA
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Hypotension, Syncope
Clinical narrative: Systemic: Syncope -Severe, Systemic: Hypotension-Severe, Additional Details: Reported blood pressure after 911 paramedics arrived was 56/59. Patient was transported to facility. Called facility 3 times to follow up, but no response yet from facility director. Will follow up again on 2/23/21 in the AM.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Autopsy, Cardiac tamponade, Death
Clinical narrative: Death on February 12, 2021 acute cardiac tamponade
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Seizure
Clinical narrative: Systemic: Seizure-Medium
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia oral, Pharyngeal paraesthesia
Clinical narrative: Client reported "tingling in back of tongue and throat."  Sensation lasted 15-20 minutes.  Resolved without medication intervention.  Client reported, "Sensation is gone.  I feel okay now."
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: The needle came out prematurely (I flinched when the nurse injected it) and some amount of the vaccine just dripped down my arm. It seemed like a lot spilled out.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling cold, Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: Site of  vaccine injection started turning red. Itchiness began within twenty minutes of receiving shot. Itchiness was bad enough to put an histamine cream on it. Next morning the arm was swelling and the injection spot swollen more. The redness was worse and the area now hot. I had a slight temperature for a day, The temp went away, chills followed and I was ice cold. Day two after shot the chills left. The spot of injection was getting redder, swelling more and itchy. I am on day three and my arm is swollen, red and itchy.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site warmth, Peripheral swelling, Pyrexia
Clinical narrative: Site of  vaccine injection started turning red. Itchiness began within twenty minutes of receiving shot. Itchiness was bad enough to put an histamine cream on it. Next morning the arm was swelling and the injection spot swollen more. The redness was worse and the area now hot. I had a slight temperature for a day, The temp went away, chills followed and I was ice cold. Day two after shot the chills left. The spot of injection was getting redder, swelling more and itchy. I am on day three and my arm is swollen, red and itchy.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure abnormal, Dizziness, Tunnel vision
Clinical narrative: Pt reported feeling "woozy" w/ "tunnel vision" whileamb w/ PT to observation area.  Pt immediately sat in   chair at 9:10am w/ BP 149/82 and HR 74.  Pt then t/f to stretcher and placed in supine position.   VS cont to be monitored:9:33 - supine - 146/84, 67 denied symptoms    c/o "tunnel vision"9:49 - supine - 138/81, 68 denied symptoms   9:55 - pt sat at EOB and denied symptoms pt was givenwater and crackers w/o issue   10:12 - standing - 132/90, 80 denied symptoms, pt amb across room and back (about 50') w/o LOB or sx
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest pain
Clinical narrative: 1st vaccine 1/26/21; 2nd vaccine 2/19/21; developed chest pain 2/22/21 and went to ED and admitted to hospital, DX: Chest pain, unspecified type  R07.9 786.50
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pain, Pyrexia
Clinical narrative: Fever 101-103, soreness, fatigue and chills
Age: 49.0
Sex: M
Vaccine: HEP, HEPA
Symptoms: Incorrect dose administered
Clinical narrative: Patient came into the office for a routine appointment and I was told by the provider, he was going to be getting Hepatitis A and Hepatitis B injections at checkout. I went and checked his insurance, and went to our fridge that holds private stock injections and found private doses of both Hepatitis A and Hepatitis B injections, grabbed them and the supplies needed for his injection and doubled check to ensure I had the right Patient, Right insurance and gave him both injections. He then checked out and I went back to my desk and charted and documented injections in between patients.    - It was actually a Pediatric dose of both Hepatitis A and B he received. When I was notified about him receiving the pediatric injection, the Vares form was filled out, an incident report was documented, and the patient was informed that at his next appt he would have to come in and get the Adult dose of the injection.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Vital signs measurement
Clinical narrative: Client verbalized feeling dizzy after receiving the vaccine.  Client was then evaluated by Fire Rescue and cleared to go home at 8:57 am after symptoms resolved.
Age: 19.0
Sex: F
Vaccine: HEPA
Symptoms: Incorrect dose administered
Clinical narrative: Patient came into the office for a routine appointment and I was told by the provider, she was going to be getting Hepatitis A injection at checkout. I went and checked her insurance, and went to our fridge that holds private stock injections and found private doses of both Hepatitis A , grabbed them and the supplies needed for her injection and doubled check to ensure I had the right Patient, Right insurance and gave injection. She then checked out and I went back to my desk and charted and documented injections in between patients.    - It was actually a Pediatric dose of both Hepatitis A she received. When I was notified about her receiving the pediatric injection, the Vares form was filled out, an incident report was documented, and the patient was informed that at her next appt she would have to come in and get the Adult dose of the injection.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site induration, Injection site pruritus, Injection site swelling, Injection site urticaria, Injection site warmth
Clinical narrative: between 7-8 days after the vaccination, itchiness occurring near the injection site. Within 12 hours after initial itchiness, large (2.5" diameter) hive like spot appearing: red splotchiness, raised skin, hard to the touch, round, warm, extremely itchy. Still in the process of symptoms; this reaction started less than 24 hours ago.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Confusional state, Dizziness, Eye pain, Headache
Clinical narrative: #1 Moderna vaccine 1/22/21 @1210hours  at right deltoid Date of second shot was not recorded for report 2nd vaccine caused side effects started the next day - woke up feeling very weak, headache, eyes hurting, fever not measured, felt confused, dizzy, vomited x2
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: #1 Moderna vaccine 1/22/21 @1210hours  at right deltoid Date of second shot was not recorded for report 2nd vaccine caused side effects started the next day - woke up feeling very weak, headache, eyes hurting, fever not measured, felt confused, dizzy, vomited x2
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dizziness, Limb discomfort
Clinical narrative: Tightness in left arm immediately; dizziness - 2 hrs later; significant diarrhea from 8pm - 4am.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site induration, Injection site pruritus, Injection site rash
Clinical narrative: One week after the injection the site got hard with a red itchy rash .  I am using ice and cortisone cream to treat it. It has been 2 days at this point with no change.
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Activated partial thromboplastin time, Blood albumin, Blood ethanol, Blood glucose, Blood lactic acid
Clinical narrative: Insomnia, mania, severe psychosis
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood magnesium, Blood phosphorus, Blood thyroid stimulating hormone, Ceruloplasmin, Cryptococcus test
Clinical narrative: Insomnia, mania, severe psychosis
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Differential white blood cell count, Drug screen, Electrocardiogram, Full blood count, Haemoglobin
Clinical narrative: Insomnia, mania, severe psychosis
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Influenza A virus test, Influenza B virus test, Insomnia, International normalised ratio, Lipids
Clinical narrative: Insomnia, mania, severe psychosis
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Liver function test, Magnetic resonance imaging brain, Mania, Metabolic function test, Protein total
Clinical narrative: Insomnia, mania, severe psychosis
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Prothrombin time, Psychotic disorder, SARS-CoV-2 test, Scan with contrast, Toxicologic test
Clinical narrative: Insomnia, mania, severe psychosis
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Urine analysis, Vitamin B12
Clinical narrative: Insomnia, mania, severe psychosis
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood ethanol normal, Blood glucose decreased, Blood lactic acid normal, CSF glucose normal, CSF lymphocyte count
Clinical narrative: Insomnia, mania, severe psychosis
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: CSF monocyte count, CSF protein normal, CSF red blood cell count, Cerebral atrophy, Condition aggravated
Clinical narrative: Insomnia, mania, severe psychosis
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cryptococcus test, Delusion, Drug screen negative, Electroencephalogram abnormal, Full blood count normal
Clinical narrative: Insomnia, mania, severe psychosis
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Grandiosity, Insomnia, Lymphocyte count decreased, Magnetic resonance imaging brain abnormal, Metabolic function test
Clinical narrative: Insomnia, mania, severe psychosis
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Monocyte count increased, Periventricular leukomalacia, Pressure of speech, Protein total increased, Psychotic symptom
Clinical narrative: Insomnia, mania, severe psychosis
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Red blood cell count decreased, Speech disorder
Clinical narrative: Insomnia, mania, severe psychosis
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Activated partial thromboplastin time, Blood albumin, Blood ethanol, Blood glucose, Blood lactic acid
Clinical narrative: Acute onset of psychotic symptoms on 2/14/2021 including pressured speech, delusions, grandiosity, continued insomnia. Had been admitted to Inpatient psychiatry. Discharged and admitted to neurology service. Some improvement prior to starting depakote. Sleep improved with seroquel 25mg PO qHS. Gradual improvement of speech, delusions, insomnia. Patient seemed to have insight into his delusions per psychiatry consult.
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood magnesium, Blood phosphorus, Blood thyroid stimulating hormone, Ceruloplasmin, Cryptococcus test
Clinical narrative: Acute onset of psychotic symptoms on 2/14/2021 including pressured speech, delusions, grandiosity, continued insomnia. Had been admitted to Inpatient psychiatry. Discharged and admitted to neurology service. Some improvement prior to starting depakote. Sleep improved with seroquel 25mg PO qHS. Gradual improvement of speech, delusions, insomnia. Patient seemed to have insight into his delusions per psychiatry consult.
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Differential white blood cell count, Drug screen, Electrocardiogram, Full blood count, Haemoglobin
Clinical narrative: Acute onset of psychotic symptoms on 2/14/2021 including pressured speech, delusions, grandiosity, continued insomnia. Had been admitted to Inpatient psychiatry. Discharged and admitted to neurology service. Some improvement prior to starting depakote. Sleep improved with seroquel 25mg PO qHS. Gradual improvement of speech, delusions, insomnia. Patient seemed to have insight into his delusions per psychiatry consult.
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Influenza A virus test, Influenza B virus test, Insomnia, International normalised ratio, Lipids
Clinical narrative: Acute onset of psychotic symptoms on 2/14/2021 including pressured speech, delusions, grandiosity, continued insomnia. Had been admitted to Inpatient psychiatry. Discharged and admitted to neurology service. Some improvement prior to starting depakote. Sleep improved with seroquel 25mg PO qHS. Gradual improvement of speech, delusions, insomnia. Patient seemed to have insight into his delusions per psychiatry consult.
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Liver function test, Magnetic resonance imaging brain, Mania, Metabolic function test, Protein total
Clinical narrative: Acute onset of psychotic symptoms on 2/14/2021 including pressured speech, delusions, grandiosity, continued insomnia. Had been admitted to Inpatient psychiatry. Discharged and admitted to neurology service. Some improvement prior to starting depakote. Sleep improved with seroquel 25mg PO qHS. Gradual improvement of speech, delusions, insomnia. Patient seemed to have insight into his delusions per psychiatry consult.
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Prothrombin time, Psychotic disorder, SARS-CoV-2 test, Scan with contrast, Toxicologic test
Clinical narrative: Acute onset of psychotic symptoms on 2/14/2021 including pressured speech, delusions, grandiosity, continued insomnia. Had been admitted to Inpatient psychiatry. Discharged and admitted to neurology service. Some improvement prior to starting depakote. Sleep improved with seroquel 25mg PO qHS. Gradual improvement of speech, delusions, insomnia. Patient seemed to have insight into his delusions per psychiatry consult.
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Urine analysis, Vitamin B12
Clinical narrative: Acute onset of psychotic symptoms on 2/14/2021 including pressured speech, delusions, grandiosity, continued insomnia. Had been admitted to Inpatient psychiatry. Discharged and admitted to neurology service. Some improvement prior to starting depakote. Sleep improved with seroquel 25mg PO qHS. Gradual improvement of speech, delusions, insomnia. Patient seemed to have insight into his delusions per psychiatry consult.
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood ethanol normal, Blood glucose decreased, Blood lactic acid normal, CSF glucose normal, CSF lymphocyte count
Clinical narrative: Acute onset of psychotic symptoms on 2/14/2021 including pressured speech, delusions, grandiosity, continued insomnia. Had been admitted to Inpatient psychiatry. Discharged and admitted to neurology service. Some improvement prior to starting depakote. Sleep improved with seroquel 25mg PO qHS. Gradual improvement of speech, delusions, insomnia. Patient seemed to have insight into his delusions per psychiatry consult.
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: CSF monocyte count, CSF protein normal, CSF red blood cell count, Cerebral atrophy, Condition aggravated
Clinical narrative: Acute onset of psychotic symptoms on 2/14/2021 including pressured speech, delusions, grandiosity, continued insomnia. Had been admitted to Inpatient psychiatry. Discharged and admitted to neurology service. Some improvement prior to starting depakote. Sleep improved with seroquel 25mg PO qHS. Gradual improvement of speech, delusions, insomnia. Patient seemed to have insight into his delusions per psychiatry consult.